Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2019. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3764401014 | Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3764402019 | Goserelin (as goserelin acetate) 10.8 mg prolonged-release subcutaneous implant | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Is a | Product containing goserelin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has active ingredient | Goserelin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has active ingredient | Synthetic hormone agent | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has active ingredient | Substance with gonadotropin mechanism of action (substance) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has manufactured dose form | Implant | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has manufactured dose form | Prolonged-release subcutaneous implant | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Is a | TEMPORARY parent for CDs that are not updated | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has precise active ingredient | Goserelin acetate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has unit of presentation | Implant | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has basis of strength substance | Goserelin | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has presentation strength numerator value | 10.8 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Is a | Product containing carboxylic acid and/or carboxylic acid derivative (product) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has presentation strength denominator unit | Implant | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Is a | Product containing acetic acid and/or acetic acid derivative (product) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Is a | Product containing only goserelin in subcutaneous dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Is a | Product containing only goserelin in parenteral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has manufactured dose form | Prolonged-release subcutaneous implant | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route | implant.subcutaneous ontology form and route | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) dose form indicator | Discrete dose form indicator | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration | Subcutaneous route | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) controlled drug category | Controlled drug category No Controlled Drug Status | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has active ingredient | Goserelin acetate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has manufactured dose form | Implant | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has unit of presentation | Implant | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has manufactured dose form | Prolonged-release subcutaneous implant | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Is a | Goserelin | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has manufactured dose form | Prolonged-release subcutaneous implant | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has manufactured dose form | Prolonged-release subcutaneous implant | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has manufactured dose form | Subcutaneous dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has manufactured dose form | Implant | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has NHS dm+d (dictionary of medicines and devices) basis of strength substance | Goserelin | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has specific active ingredient | Goserelin acetate | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has dispensed dose form | Implant | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Is a | Virtual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Has basis of strength substance | Goserelin | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Goserelin 10.8mg implant - product | Is a | False | Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Zoladex LA 10.8mg implant SafeSystem pre-filled syringes (Pilsco Ltd) | Is a | False | Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Zoladex LA 10.8mg implant SafeSystem pre-filled syringes (Pharmaram Ltd) | Is a | False | Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Zoladex LA 10.8mg implant pre-filled syringes (AstraZeneca) | Is a | False | Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Zoladex LA 10.8mg implant pre-filled syringes (PI) (Dowelhurst Ltd) | Is a | False | Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Zoladex 10.8mg implant pre-filled syringes (PI) (Waymade Ltd) | Is a | False | Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Zoladex LA 10.8mg implant SafeSystem pre-filled syringes (CST Pharma Ltd) | Is a | False | Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Goserelin 10.8mg implant pre-filled syringes 1 pre-filled disposable injection | Is pack of | False | Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Zoladex LA 10.8mg implant pre-filled syringes (Doncaster Pharmaceuticals Ltd) | Is a | False | Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Zoladex LA 10.8mg implant pre-filled syringes (Sigma Pharmaceuticals Plc) | Is a | False | Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Goserelin 10.8mg implant pre-filled syringes 1 pre-filled disposable injection | Has VMP | False | Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Zoladex LA 10.8mg implant SafeSystem pre-filled syringes (Mawdsley-Brooks & Company Ltd) | Is a | False | Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Zoladex LA 10.8mg implant SafeSystem pre-filled syringes (Lexon (UK) Ltd) | Is a | False | Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Zoladex LA 10.8mg implant SafeSystem pre-filled syringes (Necessity Supplies Ltd) | Is a | False | Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Inferred relationship | Existential restriction modifier | |
| Zoladex LA 10.8mg implant SafeSystem pre-filled syringes (Originalis B.V.) | Is a | False | Product containing precisely goserelin (as goserelin acetate) 10.8 milligram/1 each prolonged-release subcutaneous implant (clinical drug) | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR